Novartis R & D update highlights industry leading development pipeline including potential blockbusters and advanced therapy platforms

Throughout 2018, Novartis took strong action to focus the company and its capital towards the Innovative Medicines Division, resulting in an industry leading pipeline. Today Novartis holds an R&D and investor update in London which will provide deeper insights into the pipeline including the below.

Source: World Pharma News - November 5, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news